U.S. Markets closed
  • S&P 500

    4,473.75
    -6.95 (-0.16%)
     
  • Dow 30

    34,751.32
    -63.07 (-0.18%)
     
  • Nasdaq

    15,181.92
    +20.42 (+0.13%)
     
  • Russell 2000

    2,232.91
    -1.54 (-0.07%)
     
  • Crude Oil

    72.65
    +0.04 (+0.06%)
     
  • Gold

    1,753.30
    -3.40 (-0.19%)
     
  • Silver

    22.61
    -0.14 (-0.62%)
     
  • EUR/USD

    1.1769
    -0.0057 (-0.4825%)
     
  • 10-Yr Bond

    1.3310
    +0.0270 (+2.07%)
     
  • Vix

    18.69
    +0.51 (+2.81%)
     
  • GBP/USD

    1.3800
    -0.0035 (-0.2539%)
     
  • USD/JPY

    109.7200
    +0.3600 (+0.3292%)
     
  • BTC-USD

    47,651.49
    -641.15 (-1.33%)
     
  • CMC Crypto 200

    1,209.85
    -23.44 (-1.90%)
     
  • FTSE 100

    7,027.48
    +10.99 (+0.16%)
     
  • Nikkei 225

    30,323.34
    -188.36 (-0.62%)
     

Investors Who Bought inTEST (NYSEMKT:INTT) Shares A Year Ago Are Now Down 52%

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

This month, we saw the inTEST Corporation (NYSEMKT:INTT) up an impressive 30%. But that's not enough to compensate for the decline over the last twelve months. Specifically, the stock price slipped by 52% in that time. The share price recovery is not so impressive when you consider the fall. You could argue that the sell-off was too severe.

See our latest analysis for inTEST

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During the last year inTEST grew its earnings per share, moving from a loss to a profit.

Earnings per share growth rates aren't particularly useful for comparing with the share price, when a company has moved from loss to profit. But we may find different metrics more enlightening.

In contrast, the 23% drop in revenue is a real concern. If the market sees the weak revenue as jeopardising EPS, that could explain the lower share price.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

AMEX:INTT Income Statement April 15th 2020
AMEX:INTT Income Statement April 15th 2020

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

A Different Perspective

We regret to report that inTEST shareholders are down 52% for the year. Unfortunately, that's worse than the broader market decline of 3.5%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 6.5% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. It's always interesting to track share price performance over the longer term. But to understand inTEST better, we need to consider many other factors. For instance, we've identified 3 warning signs for inTEST (1 shouldn't be ignored) that you should be aware of.

But note: inTEST may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.